OPK vs PATH · rev $183.6M vs P/E 19, rev $1.61B
Opko Health Inc (OPK) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Opko Health Inc (OPK) is a diagnostics & research company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported OPK revenue for 2024-12-31 was $183.6M. Net income was $14.0M. Revenue was up 5.8% from 2024-09-30 to 2024-12-31. OPK currently screens at market cap $1.07B.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
OPK currently screens at market cap $1.07B. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the OPK and PATH stock pages for the full models.
Not investment advice.